are glp 1 agonists safe GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1 Agonists In Obesity

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

More on, ADA and AACE Guidelines prefer GLP1RA over DPP4i for patients with established ASCVD or indicato...

SaveHealth reports that Zepbound and Wegovy, both FDA-approved weight loss injectables, differ in mechanisms and efficacy

However, they also affect how the digestive system works

We share the protocol that we believe can help the plastic surgery team standardize safety strategies to be considered prior to elective surgery in patients who are treated with GLP-1 RA

Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway